12:00 AM
 | 
Sep 10, 2012
 |  BC Week In Review  |  Company News  |  Deals

Medicis, Valeant Pharmaceuticals deal

Valeant will acquire dermatology company Medicis for $44 per share in cash, which values Medicis at about $2.6 billion based on 59.8 million shares outstanding at Aug. 6. The price is a 39% premium to Medicis' close...

Read the full 161 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >